CytRx Board Must Face Claims It 'Spring-Loaded' Options
A Delaware Chancery judge declined Thursday to throw out derivative claims alleging biopharmaceutical firm CytRx Corp.'s board members gave themselves "spring-loaded" stock options before positive clinic trial results for one of...To view the full article, register now.
Already a subscriber? Click here to view full article